JUser: :_load: Unable to load user with ID: 1543
Sunday, 21 September 2008 19:14

FTA sues fraudulent cancer cure companies

The Federal Trade Commission (FTC) wrote letters to Internet companies advertising and selling cancer cure products that it claims are unsubstantiated medically. The FTA sued the e-companies that did not stop such alleged fraudulent and deceitful practices.

In all, 112 letters of warning were sent between August 2007 and January 2008 by the FTC informing Internet companies about their alleged claims with regard to cancer cures.

The FTC stated that many companies stopped or changed their advertising based on these warning letters.

Each letter warned that “…they must have adequate substantiation for any health claims they make about their products.”

Almost 30% of the companies have since closed their sites or removed the unsubstantiated cancer treatment claims. The FTC reviewed the other 70% of the cases to determine if legal action could be taken against them.

The FTC determined that 23 companies could be held legally responsible. The U.S. agency sent warning letters to these companies because “… the marketed products claimed to cure, treat, mitigate, or prevent cancer, and because they are not proven to be safe and effective for their labeled use, they are unapproved new drugs marketed in violation of the federal Food, Drug, and Cosmetic Act.” [Federal Trade Commission: “FTC Sweep Stops Peddlers of Bogus Cancer Cures ”]

In parallel, the Canadian Competition Bureau sent warning letters to Canadian companies that were selling fraudulent cancer cures online..

The results of this investigation were then announced on Thursday, September 18, 2008. It stated that officials with the U.S. Federal Trade Commission (FTC), along with the U.S. Food and Drug Administration (FDA) and related Canadian agencies, have charged five companies with “making false and misleading claims for cancer cures.” [The Washington Post: “FTC warns consumers about bogus cancer cures”]

Please read page two for additional comments and information on this cancer cure product story, including the names of the companies cited by the FTC.

Lydia Parnes, the director of the FTC Bureau of Consumer Protection, states, "As long as products have been sold there has been somebody out there selling snake oil to consumers.”

Parnes added, “We found all of these claims to be nothing short of breathtaking, and not in a good way.” [The Los Angeles Times: “FTC cracks down on bogus online cancer cures”]

According to the U.S. Federal Trade Commission, the five alleged bogus cancer cure companies, which are currently under litigation (being sued) by the FTC, are:

•    Omega Supply, San Diego, California

•    Native Essence Herb Company (https://www.herbmed.com/), El Prado, New Mexico (FTC lawsuit)

•    Daniel Chapter One (https://www.danielchapterone.com/), Portsmouth, Rhode Island (FTC lawsuit)

•    Gemtronics, Inc. (https://www.agaricus.net/ and https://raaxagaricus.com/), Franklin, North Carolina (FTC letter)

•    Herbs for Cancer (https://www.herbsforcancer.com/, closed on 9/21/08), Surprise, Arizona (FTC letter)

Please read page three for another six company who have already settled their cases with the FTC.

Another six companies have already settled their cases brought forth by the FTA.

These six company, according to the FTC website “FTC Sweep Stops Peddlers of Bogus Cancer Cures”, are:

•    Ni-Gen Nutrition, Troy, Michigan, which allegedly marketed an electrolyte liquid and apricot seeds as cures.

•    Westberry Enterprises of Pineville, Louisiana, which allegedly sold teas that contained algae and other ingredients (FTC lawsuit)

•    Jim Clark's All Natural Cancer Therapy of Louisville, Kentucky, which allegedly sold digestive enzymes and coral calcium as treatments (FTC lawsuit)

•    Bioque Technologies, Inc. (https://www.bioque.com/) of Blacksburg, Virginia)

•    Cleansing Time Pro (https://www.cleansingtimepro.com/) website valid, but lacking of normal company information

•    Premium-essiac-tea-4less (https://www.premium-essiac-tea-4less.com/)

The six companies already settling their lawsuits from the FTA have paid fines ranging from $9,000 to $250,000, according to Parnes.

Page four contains a new FTC website that provided informed and accurate information on "bogus" cancer cures.

The FTC has set up a new website called “CURE-ious? Ask.” that discusses bogus cancer cures.

According to the FTC, the website “tells consumers how to spot and report bogus claims they see online, and urges people with cancer to talk to their treatment team about any products they’d like to try."

In addition, the new FTC website includes a list of resources on cancer treatments from various federal government agencies.

As stated earlier, the Federal Trade Commission's article “FTC Sweep Stops Peddlers of Bogus Cancer Cures”, contains additional information on these cancer cure lawsuits.

Please read it for important information on these alleged fradulent cancer cure products and companies.

Subscribe to ITWIRE UPDATE Newsletter here

Now’s the Time for 400G Migration

The optical fibre community is anxiously awaiting the benefits that 400G capacity per wavelength will bring to existing and future fibre optic networks.

Nearly every business wants to leverage the latest in digital offerings to remain competitive in their respective markets and to provide support for fast and ever-increasing demands for data capacity. 400G is the answer.

Initial challenges are associated with supporting such project and upgrades to fulfil the promise of higher-capacity transport.

The foundation of optical networking infrastructure includes coherent optical transceivers and digital signal processing (DSP), mux/demux, ROADM, and optical amplifiers, all of which must be able to support 400G capacity.

With today’s proprietary power-hungry and high cost transceivers and DSP, how is migration to 400G networks going to be a viable option?

PacketLight's next-generation standardised solutions may be the answer. Click below to read the full article.


WEBINAR PROMOTION ON ITWIRE: It's all about webinars

These days our customers Advertising & Marketing campaigns are mainly focussed on webinars.

If you wish to promote a Webinar we recommend at least a 2 week campaign prior to your event.

The iTWire campaign will include extensive adverts on our News Site itwire.com and prominent Newsletter promotion https://www.itwire.com/itwire-update.html and Promotional News & Editorial.

This coupled with the new capabilities 5G brings opens up huge opportunities for both network operators and enterprise organisations.

We have a Webinar Business Booster Pack and other supportive programs.

We look forward to discussing your campaign goals with you.



Share News tips for the iTWire Journalists? Your tip will be anonymous




Guest Opinion

Guest Interviews

Guest Reviews

Guest Research

Guest Research & Case Studies

Channel News